Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 5/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.74 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.74 |
| ▸ | CASP7 | P55210 | 1/20 | 0.74 |
| ▸ | MAPT | P10636 | 6/20 | 0.71 |
| ▸ | MEN1 | O00255 | 5/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.71 |
| ▸ | GAA | P10253 | 2/20 | 0.71 |
| ▸ | PKM | P14618 | 1/20 | 0.71 |
| ▸ | IDO1 | P14902 | 1/20 | 0.55 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | GBA1 | P04062 | 1/20 | 0.48 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.48 |
| ▸ | WNK1 | Q9H4A3 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11506844 | 0.91 | ALDH1A1 (0.89) | MAPK1TDP1L3MBTL1ALDH1A1CASP7 | |
| SCHEMBL11507400 | 0.86 | ALDH1A1 (0.79) | MAPK1TDP1L3MBTL1ALDH1A1CASP7 | |
| SCHEMBL230292 | 0.85 | TDP1 (1.00) | MAPK1TDP1L3MBTL1ALDH1A1CASP7 | |
| SCHEMBL31333098 | 0.85 | TDP1 (1.00) | MAPK1TDP1L3MBTL1ALDH1A1CASP7 | |
| SCHEMBL27760804 | 0.85 | MAPK1 (0.54) | MAPK1TDP1L3MBTL1ALDH1A1CASP7 | |
| SCHEMBL5718635 | 0.84 | MAPK1 (0.77) | MAPK1TDP1L3MBTL1ALDH1A1CASP7 | |
| Nitrogen SCHEMBL27702068 | 0.83 | MAPK1 (0.51) | MAPK1TDP1L3MBTL1ALDH1A1CASP7 | |
| SCHEMBL11676980 | 0.83 | MAPK1 (0.74) | MAPK1TDP1L3MBTL1ALDH1A1CASP7 | |
| SCHEMBL497223 | 0.83 | MAPK1 (0.74) | MAPK1TDP1L3MBTL1ALDH1A1CASP7 | |
| SCHEMBL109703 | 0.83 | MAPT (1.00) | MAPK1TDP1L3MBTL1ALDH1A1CASP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106831864-B | Based on phenylbenzimidazol monopole thermal excitation delayed fluorescence main body, the preparation method and application of electron transport material | 黑龙江大学 | 2019-04-19 | — | — | CN | claimed |
| CN-106831864-A | Based on phenylbenzimidazol monopole thermal excitation delayed fluorescence main body, the preparation method and application of electron transport material | 黑龙江大学 | 2017-06-13 | — | — | CN | claimed |
| EP-1602648-B2 | Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same | IDEMITSU KOSAN CO (JP) | 2025-03-26 | — | — | EP | disclosed |
| US-11056651-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-07-06 | — | — | US | disclosed |
| CN-106450039-B | Organic light emitting device | 三星显示有限公司 | 2020-03-06 | — | — | CN | disclosed |
| US-RE47654-E1 | Organic electroluminescence device | IDEMITSU KOASN CO., LTD. (JP) | 2019-10-22 | — | — | US | disclosed |
| CN-106831864-B | Based on phenylbenzimidazol monopole thermal excitation delayed fluorescence main body, the preparation method and application of electron transport material | 黑龙江大学 | 2019-04-19 | — | — | CN | disclosed |
| US-9974779-B2 | Piperidine derivatives as human papilloma virus inhibitors | VAXART, INC. (US) | 2018-05-22 | — | — | US | disclosed |
| US-20180021318-A9 | PIPERIDINE DERIVATIVES AS HUMAN PAPILLOMA VIRUS INHIBITORS | VAXART, INC. | 2018-01-25 | — | — | US | disclosed |
| US-9748496-B2 | Nitrogenated heterocyclic derivative, electron-transporting material for organic electroluminescent elements, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2017-08-29 | — | — | US | disclosed |
| EP-2524913-B1 | NITROGENATED HETEROCYCLIC RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | IDEMITSU KOSAN CO (JP) | 2017-07-26 | — | — | EP | disclosed |
| WO-2007135106-A1 | PIPERIDINE DERIVATIVES AS HUMAN PAPILLOMA VIRUS INHIBITORS | ANACONDA PHARMA (FR) | 2007-11-29 | — | — | WO | disclosed |
| US-20070200490-A1 | Nitrogenous Heterocycle Derivative, And Organic Electroluminescent Element Employing The Same | IDEMITSU KASON CO.LTD (JP) | 2007-08-30 | — | — | US | disclosed |
| US-20070138950-A1 | NITROGENOUS HETEROCYCLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2007-06-21 | — | — | US | disclosed |
| US-20070138950-A1 | NITROGENOUS HETEROCYCLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2007-06-21 | — | — | US | disclosed |
| EP-1734038-A1 | NITROGENOUS HETEROCYCLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2006-12-20 | — | — | EP | disclosed |
| US-20060147747-A1 | 2-[4-(10-naphthalene-2-yl-anthracene-9-yl)-phenyl]-1-phenyl-1H-benzimidazole; elevation of luminance and of efficiency in light emission even under low driving voltage | IDEMITSU KOSAN CO., LTD. (JP) | 2006-07-06 | — | — | US | disclosed |
| CN-1784388-A | Nitrogen-containing heterocyclic derivative and organic electroluminescent element using same | IDEMITSU KOSAN CO (JP) | 2006-06-07 | — | — | CN | disclosed |
| EP-1602648-A1 | NITROGEN-CONTAINING HETEROCYCLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2005-12-07 | — | — | EP | disclosed |
| EP-0374991-A1 | New antimicrobial phenazine derivatives, method for their preparation, compositions containing them, and their use in therapy | WESTMART HILL LIMITED (IE) | 1990-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070200490-A1 | Nitrogenous Heterocycle Derivative, And Organic Electroluminescent Element Employing The Same | RPS3A, NCOA3, HNRNPA0 | MAPK1 1144/4885TDP1 2403/4885L3MBTL1 816/4885 |
| US-20180021318-A9 | PIPERIDINE DERIVATIVES AS HUMAN PAPILLOMA VIRUS INHIBITORS | POLI, VHL, EBNA1BP2 | MAPK1 3238/4885TDP1 1151/4885L3MBTL1 4048/4885 |
| US-20070138950-A1 | NITROGENOUS HETEROCYCLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | EHD1, HCN2, ODC1 | MAPK1 1605/4885TDP1 1246/4885L3MBTL1 1547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.